Pfizer’s COVID-19 vaccine is more than 90% effective in children, and if regulators give a nod shots could begin in early November. ...
Researchers from Yale University, US, tracked more than 340,000 adults across 600 villages in rural Bangladesh. The findings, published as a preprint,...
Pfizer Inc and BioNTech’s COVID-19 vaccine appeared to work against a key mutation in the highly transmissible new variants of the coronavirus...
The Oxford vaccine, which also has a tie-up with the Serum Institute of India, is expected to win approval in the UK...
President Trump has been bullish about a coronavirus vaccine — so much so that experts have had to talk him off a...